Aduro BioTech Inc Logo Image

Aduro BioTech Inc

Aduro BioTech Inc Banner Image

Most Recent Annual Report

2015 Annual Report and Form 10K

Aduro BioTech Inc

Aduro BioTech Inc does not currently have any hardcopy reports available on AnnualReports.com. Click the button below to be notified when hardcopies become available.



About Aduro BioTech Inc

51-200 Employees
Based in Berkeley, California

Aduro BioTech, Inc., a clinical-stage immuno-oncology company, focuses on the development of technology platforms designed to stimulate robust and durable immune responses against cancer. Its lead product candidate is CRS-207, which is in a Phase IIb clinical trial for the treatment of metastatic pancreatic cancer and unresectable malignant pleural mesothelioma.

Ticker:
ADRO
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol